Results showing once-weekly subcutaneous semaglutide, as an adjunct to intensive behavioral therapy and an initial low calorie diet, induced weight loss that was 10.3% greater compared with placebo over 68 weeks in people with obesity or overweight, were published today in JAMA. The findings, from the phase 3, randomized, double-blind STEP 3 study for the
0 Comments
Professor Willie Hamilton specialises in primary care diagnostics at the University of Exeter. Comment and opinion from Cancer Research UK’s community of experts. The opinions outlined in this article do not necessarily represent the views of Cancer Research UK. The original cancer problem was that we weren’t testing smartly enough. When I became a GP
0 Comments
NEW BRUNSWICK, N.J., February 19, 2021– Johnson & Johnson (NYSE: JNJ) (the Company) announced that Janssen-Cilag International N.V. has submitted for Emergency Use Listing (EUL) to the World Health Organization (WHO) for the investigational single-dose Janssen COVID-19 vaccine candidate. The data package delivered today includes interim efficacy and safety results from the Phase 3 ENSEMBLE clinical
0 Comments
Treatment for Attention Deficit Hyperactivity Disorder (ADHD) Supernus Resubmits New Drug Application for SPN-812 for the Treatment of ADHD in Pediatric Patients ROCKVILLE, Md., Feb. 08, 2021 (GLOBE NEWSWIRE) – Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced it has resubmitted its
0 Comments
The author, entertainment entrepreneur, and life coach opens up about her memoir – Falling Love Notes – her experience with grief, misconceptions about being an adoptee, and why she wants to reach others with her story Hi Samantha! What inspired you to tell your story with Falling Love Notes? I’ve always wanted to share my
0 Comments
Slight differences in clinical features can help physicians distinguish between two rare but similar forms of autoimmune brain inflammation in children, a new study by UT Southwestern scientists suggests. The findings, published online in Pediatric Neurology, could provide patients and their families with a better prognosis and the potential to target treatments specific to each
0 Comments
This content originally appeared on Integrated Diabetes Services. Republished with permission. By Gary Scheiner MS, CDCES A long, long time ago, before the days of coronavirus, there was a little diabetes care practice called Integrated Diabetes Services (we’ll just call it IDS for short). IDS taught people with diabetes all the wonderful things they can
0 Comments
Strokes are a leading cause of poor quality of life or even death in Japan and the world over. Since its characterization, several researchers have been working tooth and nail to identify drug-accessible and effective therapeutic targets for this debilitating condition. One such region of interest for drug targets is the blood-brain barrier (BBB). The
0 Comments
tisotumab vedotin Treatment for Cervical Cancer Genmab and Seagen Submit Tisotumab Vedotin Biologics License Application to the U.S. FDA for Patients with Recurrent or Metastatic Cervical Cancer COPENHAGEN, Denmark and BOTHELL, Wash.; Feb 10, 2021 – Genmab A/S (Nasdaq: GMAB) and Seagen Inc. (Nasdaq: SGEN) today announced the submission of a Biologics License Application (BLA) to the U.S. Food and Drug
0 Comments
TARRYTOWN, N.Y. and PARIS, Feb. 22, 2021 /PRNewswire/ – Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the U.S. Food and Drug Administration (FDA) has approved the PD-1 inhibitor Libtayo (cemiplimab-rwlc) for the first-line treatment of patients with advanced non-small cell lung cancer (NSCLC) whose tumors have high PD-L1 expression (tumor proportion score ≥50%), as determined by an
0 Comments
Data from an observational cohort study suggest that the presence of abandoned leads in patients with cardiac implantable electronic devices (CIEDs) should no longer be an absolute contraindication to MRI. In the study, which spanned 7 years and included 139 consecutive patients, adverse events were few, mild, and transient. The results were published online February
0 Comments
Not every cancer drug approved by the FDA receives approval and coverage in England and Canada, two studies in JAMA Internal Medicine showed. In England, a retrospective cohort study looked at 68 drugs given accelerated approval by the FDA from December 1992 to May 2017 that also received market approval in the European Union. The
0 Comments
Where do I get my information from: http://armandoh.org/resource For more information on Haemorrhoids: http://armandoh.org/disease/anal-haemorrhoids/ http://armandoh.org/disease/ https://www.facebook.com/ArmandoHasudungan Support me: http://www.patreon.com/armando Instagram: http://instagram.com/armandohasudungan Twitter: Tweets by armando71021105 SPECIAL THANKS: Patreon members
0 Comments
Dozens of mental health hubs are being set up across England to help traumatised NHS staff struggling with their mental health, after treating patients in the COVID-19 pandemic NHS personnel are encouraged to ring one of the new hubs if they are struggling and will receive advice and referral support from psychologists, therapists, recovery workers
0 Comments
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Events of the past year have taken a huge toll on the happiness, wellness, and lifestyles of many, but especially those in the healthcare field, including psychiatrists. The newly released Medscape Psychiatrist Lifestyle, Happiness & Burnout Report 2021 reveals how psychiatrists
0 Comments